<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="093137-2018"
            EDITION="2018042">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-093981-001</RECEPTION_ID>
      <DELETION_DATE>20180607</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>42</NO_OJ>
         <DATE_PUB>20180301</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 042-093137</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:093137-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="NO"/>
         <IA_URL_GENERAL>http://ous-hf.no</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33100000">Medical equipments</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="NO">NORGE</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="NO">NORGE</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="NO">NORGE</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="NOK">5800000.00</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 162-335314</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180227</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="V">Voluntary ex ante transparency notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="V">Contract award without prior publication</PR_PROC>
         <RP_REGULATION CODE="B">European Economic Area (EEA), with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>03B15</HEADING>
         <INITIATOR>03</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Норвегия</TI_CY>
            <TI_TOWN>Осло</TI_TOWN>
            <TI_TEXT>
               <P>Медицинско оборудване</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Norsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Zdravotnické přístroje</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinsk udstyr</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Norwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medizinische Geräte</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Νορβηγία</TI_CY>
            <TI_TOWN>Όσλο</TI_TOWN>
            <TI_TEXT>
               <P>Ιατρικές συσκευές</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Norway</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medical equipments</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Equipamiento médico</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Norra</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Meditsiiniseadmed</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Norja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Lääketieteelliset laitteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Norvège</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Équipements médicaux</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Iorua, an</TI_CY>
            <TI_TOWN>Osló</TI_TOWN>
            <TI_TEXT>
               <P>Medical equipments</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinske naprave</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Norvégia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Orvosi felszerelések</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Apparecchiature mediche</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Norvegija</TI_CY>
            <TI_TOWN>Oslas</TI_TOWN>
            <TI_TEXT>
               <P>Medicinos įranga</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Norvēģija</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicīniskās ierīces</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>in-Norveġja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Tagħmir mediku</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Noorwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medische apparatuur</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Norwegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Urządzenia medyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Equipamento médico</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Echipamente medicale</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nórsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Zdravotnícke vybavenie</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinska oprema</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Medicinsk utrustning</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Oslo universitetssykehus HF</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>06923afb-ffa4-42c3-b49d-7478d61d42a6</NOTICE_UUID>
      <F15_2014 CATEGORY="ORIGINAL" FORM="F15" LG="EN">
         <DIRECTIVE VALUE="2014/24/EU"/>
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Oslo universitetssykehus HF</OFFICIALNAME>
               <NATIONALID>993 467 049</NATIONALID>
               <ADDRESS>Postboks 4950 Nydalen</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0424</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <CONTACT_POINT>Trine Kjellsen</CONTACT_POINT>
               <PHONE>+47 91667242</PHONE>
               <E_MAIL>trikje@ous-hf.no</E_MAIL>
               <n2016:NUTS CODE="NO"/>
               <URL_GENERAL>http://ous-hf.no</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>74899 E2017 KLM RH Dep. of Pharmacology UHPLC MSMS.</P>
            </TITLE>
            <REFERENCE_NUMBER>74899</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33100000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>The pharmacology department at Oslo University Hospital, Rikshospitalet, shall procure high capacity UHPLC-MS/MS equipment (CE-IVD certified), which shall be used for quantitative analyses of medicines, medicine metabolites and any bio-markers in biological sample material. The equipment must be able to analyse with two UHPLC channels simultaneously and it must be able to configure with at least 8 separation columns /analysis columns and 6-8 mobile phase systems. The equipment shall be used for monitoring medicine levels in patients and it must, therefore, be able to be used for analyses with very good operational stability, selectivity, sensitivity, precision and accuracy. The circulation time per sample on the instrument must be short and the capacity must be at least 25-30 000 samples per annum divided between at least 6 different analysis methods.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="NOK">5800000.00</VAL_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33100000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="NO"/>
               <MAIN_SITE>
                  <P>Oslo.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>The pharmacology department at Oslo University Hospital, Rikshospitalet, shall procure high capacity UHPLC-MS/MS equipment (CE-IVD certified), which shall be used for quantitative analyses of medicines, medicine metabolites and any bio-markers in biological sample material. The equipment must be able to analyse with two UHPLC channels simultaneously and it must be able to configure with at least 8 separation columns /analysis columns and 6-8 mobile phase systems. The equipment shall be used for monitoring medicine levels in patients and it must, therefore, be able to be used for analyses with very good operational stability, selectivity, sensitivity, precision and accuracy. The circulation time per sample on the instrument must be short and the capacity must be at least 25-30 000 samples per annum divided between at least 6 different analysis methods. It is a prerequisite that there are quick changes (flexibility) between analysis methods. The system must, in principle, be operable every day year round (Monday-Sunday). It must have relative sensitive mass spectrometric detection in order to enable simple sample preparation and injection of relatively small biological material. All additional components that are necessary for the analysis equipment to be operative must be included in the procurement.</P>
                  <P>A-requirements:</P>
                  <P>— The UHPLC-MSMS must be CE-IVD certified. The analyses require CE-IVD instrumentation in accordance with the EU Directive.</P>
                  <P>— Tenderers must have ready established and documented internal routines for CE-IVD that deal with documentation and reporting for all types of service visits, such as maintenance, repairs or breakdowns.</P>
                  <P>— The instrumentation must have room for at least 8 separation columns /analysis columns and valves that allow software-controlled choice of column.</P>
                  <P>— The sensitivity in the instrumentation must, as a minimum, be equivalent to S/N at 100 000:1 (1 pg reserpine on column, positive mode, unsmoothed).</P>
                  <P>— The UHPLC-MS/MS must have software-controlled switches between “waste” and mass spectrometer.</P>
                  <P>— The UHPLC must be able to mix the mobile phase from different reservoirs, so that mobile phase gradient is allowed. The technical system must be binary high pressure mixture.</P>
                  <P>— The instrumentation must be efficient in its use of space. The maximum available space for the instrumentation, with the technical periphery equipment is (BxD: 160x125 cm).</P>
                  <P>— The technical periphery equipment must be efficient in its use of space. The available space in the technical rom for vacuum pumps and a nitrogen generator is (BxDxH: 125x90x150cm).</P>
                  <P>— The instrumentation must be able to analyse with two UHPLC channels simultaneously.</P>
                  <P>— The instrumentation must have 6-8 mobil phase reservoirs.</P>
               </SHORT_DESCR>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>Service agreements.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <DIRECTIVE_2014_24_EU>
               <PT_AWARD_CONTRACT_WITHOUT_CALL>
                  <D_OUTSIDE_SCOPE/>
                  <D_JUSTIFICATION>
                     <P>The high capcaity UHPLC-MS/MS equipment must be able to be used for quantitative analysis of medicines, medicine metabolites and any biomarkers in biological sample material. The equipment must be able to analyse with two UHPLC channels simultaneously and it must be able to configure with at least 8 separation columns/analysis columns and 6-8 mobile phase systems. The equipment shall be used for monitoring medicine levels in patients and it must, therefore, be able to be used for analyses with very good operational stability, selectivity, sensitivity, precision and accuracy. Short circulation time per sample on the instrument. The capacity must be minimum 25-30 000 samples per annum, divided between at least 6 different analysis methods. It is a prerequisite that there are quick changes (flexibility) between analysis methods. The system must be operable every day year round. It must have relative sensitive mass spectrometric detection in order to enable simple sample preparation and injection of relatively small biological material.</P>
                     <P>1— The UHPLC-MSMS must be CE-IVD certified. Our analyses require CE-IVD instrumentation in accordance with the EU directive.</P>
                     <P>2— Tenderers must have ready established and documented internal routines for CE-IVD, which deal with documentation and reports for all types of service visits, such as maintenance, repairs or break down.</P>
                     <P>3— The instrumentation must have room for at least 8 separation columns /analysis columns and valves that allow software-controlled choice of column.</P>
                     <P>4— The sensitivity in the instrumentation must, as a minimum, be equivalent to S/N at 100 000:1 (1 pg reserpine on column, positive mode, unsmoothed).</P>
                     <P>5— The UHPLC-MS/MS must have software-controlled switches between “waste” and mass spectrometer.</P>
                     <P>6— The UHPLC must be able to mix the mobile phase from different reservoirs, so that mobile phase gradient is allowed. The technical system must be binary high pressure mixture.</P>
                     <P>7— The instrumentation must be efficient in its use of space. The maximum available space for the instrumentation, with the technical periphery equipment is (BxD: 160x125 cm).</P>
                     <P>8— The technical periphery equipment must be efficient in its use of space.</P>
                     <P>9— The available space in the technical rom for vacuum pumps and a nitrogen generator is (BxDxH: 125x90x150cm).</P>
                     <P>10— The instrumentation must be able to analyse with two UHPLC channels simultaneously.</P>
                     <P>11— The instrumentation must have 6-8 mobile phase reservoirs.</P>
                     <P>The assumption is that Waters is the only supplier who, due to technical reasons, can deliver in accordance with the requirements. The intention notice is pursuant to the public procurement regulations § 21-5. The terms in FOA § 13-4 (2) and 13-1 (5) are deemed to be fulfilled as well as the value of the full service contract for the instrument´s lifetime.</P>
                  </D_JUSTIFICATION>
               </PT_AWARD_CONTRACT_WITHOUT_CALL>
            </DIRECTIVE_2014_24_EU>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 162-335314</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-26</DATE_CONCLUSION_CONTRACT>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Waters</OFFICIALNAME>
                     <ADDRESS>Forskningsparken Gaustallen 21</ADDRESS>
                     <TOWN>Oslo</TOWN>
                     <POSTAL_CODE>0372</POSTAL_CODE>
                     <COUNTRY VALUE="NO"/>
                     <PHONE>+47 63846050</PHONE>
                     <n2016:NUTS CODE="NO"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="NOK">5800000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Oslo Universitetssykehus HF</OFFICIALNAME>
               <ADDRESS>Sognvannsveien 20</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0372</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <PHONE>+47 23071580</PHONE>
               <E_MAIL>mtu-anbud@ous-hf.no</E_MAIL>
               <URL>www.ous-hf.no</URL>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>Deadline for lodging appeals:</P>
               <P>Friday 8 March.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-02-27</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F15_2014>
   </FORM_SECTION>
</TED_EXPORT>
